(Q42201210)

18 October 2017

Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis (English)

1 reference

18 October 2017

0 references

1 reference

1 reference

3

Thomas F Patterson

1 reference

PMCID

1426916

18 October 2017

William R. Kirkpatrick

series ordinal

1

object named as

William R Kirkpatrick

1 reference

18 October 2017

Brent J Coco

2

1 reference

PMCID

1426916

18 October 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Antimicrobial Agents and Chemotherapy

18 October 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 October 2017

50

1 reference

18 October 2017

4

1 reference

18 October 2017

1567-1569

1 reference

Combination antifungal therapy

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Aspergillosis case-fatality rate: systematic review of the literature

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Combination antifungal therapy for invasive aspergillosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426916

Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16569887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combination antifungal therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16569887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.50.4.1567-1569.2006

1 reference

18 October 2017

1 reference

18 October 2017

1 reference

PMCID

1426916